Healthcare -
Biotechnology - NASDAQ - US
$ 7.185
-4.58 %
$ 818 M
Market Cap
-3.7
P/E
Price Target
Average
119.90%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
35.23%
Net Income
Estimate
31.13%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Cogent Biosciences, Inc.
Wall Street analysts predict an average 1-year price target for COGT of $15.8 , with forecasts ranging from
a
low of
$13 to a high of $20 .
COGT Lowest Price Target
Wall Street Target
13 USD
80.93%
COGT Average Price Target
Wall Street Target
15.8 USD
119.90%
COGT Highest Price Target
Wall Street Target
20 USD
178.36%
REVENUE FORECAST
Revenue Forecast Chart COGT
EBIT FORECAST
EBIT Forecast Chart COGT
NET INCOME FORECAST
Net Income Chart COGT